Boxer Capital
San Diego, Californiaboxercap.com
Overview
Boxer Capital is a San Diego-based biotechnology investment firm, founded in 2005 as the life sciences investment arm of Tavistock Group, that invests in public and private companies across the entire drug development lifecycle.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Incyclix Bio | Apr 2026 | Series B Extension | Co-investor |
| Mirador | Jan 2026 | Series B | Co-investor |
| Zag Bio | Oct 2025 | Series A | Co-investor |
| Candid Therapeutics | Sep 2024 | Series A | Co-investor |
| Halda Therapeutics | Aug 2024 | Series B Extension | - |
Key People
Norman Z.
Senior Vice President
Danny Effinger
Director Of Investor Relations
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.